FDA's New Enforcement of 21 CFR Part 11

Overview:

FDA continues to enforce Part 11 through its new Part 11 inspection and enforcement program. Just in the last 3 years, FDA issued more than 30 warning letters with Part 11 violations. Citations are related to inadequate integrity, security and availability of electronic records but also related to validation of software and computer systems. There are many questions about the program, e.g., what inspectors are looking at what are major findings.

The webinar will have the answers. In addition, using industry proven case studies on how to avoid 483 inspectional observations and warning letters attendees will learn how to prepare their organization for trouble-free Part 11 related inspections.

Areas Covered in the Session:

• FDA's current inspection and enforcement practices
• FDA's new interpretation: learning from FDA inspection reports
• Strategy for cost-effective implementation of Part 11: A six step plan
• Justification and documentation for the FDA and your management
• Going through case studies from laboratories, offices and manufacturing with graphical workflow of records, step-by-step description, recommendations for individual Part 11 requirements with justifications and documentation for the FDA and your management
• Case studies how to avoid or respond to Part 11 related observations with corrective actions to fix current issues and preventive actions to prevent reoccurrence of the same or similar issues
• How to prepare your company for Part 11 Inspections

For Easy Implementation, Attendees Will Receive:

• Checklist: Part 11 compliance
• Case Studies: How to avoid Part 11 related 483's and Warning Letters
• SOP: Electronic Audit trail: Specifications, Implementation, Validation

Who Will Benefit:

• QC Managers
• QA Managers and Personnel
• IT Administrators
• Analysts
• Regulatory Affairs
• Training Departments
• Documentation Department
• Consultants